✦ LIBER ✦

In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer

✍ Scribed by M. Wood; K. Fudge; J. L. Mohler; A. R. Frost; F. Garcia; Min Wang; M. E. Stearns

Book ID: 110370151
Publisher: Springer
Year: 1997
Tongue: English
Weight: 497 KB
Volume: 15
Category: Article
ISSN: 0262-0898
DOI: 10.1023/a:1018421431388

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of matrix metalloproteinases

Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue

✍ Brehmer, B; Biesterfeld, S; Jakse, G 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 240 KB

Differential regulation of matrix metall

Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells

✍ Zhong Dong; Jeffrey A. Nemeth; Michael L. Cher; Kenneth C. Palmer; Robert C. Bri 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 298 KB

Tumor-stromal interactions have been suggested to be a critical factor in both tumor invasion and tumor metastasis. Here, we examined the role of tumor-stromal interactions using co-cultures of prostate cancer (PC) cells derived from primary and metastatic tumors with primary or immortalized stromal

Adenovirus-mediated expression of TIMP-1

Adenovirus-mediated expression of TIMP-1 and TIMP-2 in bone inhibits osteolytic degradation by human prostate cancer

✍ Xiyun Deng; Guangchun He; Andrea Levine; Ya Cao; Chad Mullins 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 699 KB

## Abstract Matrix metalloproteinases (MMPs) are proteolytic enzymes that play critical roles in the pathogenesis of human cancers. Clinical trials using synthetic small molecule MMP inhibitors have been carried out but with little success. Tissue inhibitors of metalloproteinases (TIMPs) are endoge

Serum metalloproteinases MMP-2, MMP-9 an

Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis

✍ Jacek Rysz; Maciej Banach; Robert A. Stolarek; Dimitri P. Mikhailidis; Aleksandr 📂 Article 📅 2009 🏛 Springer Netherlands 🌐 English ⚖ 295 KB

Expression of matrix metalloproteinases

Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis of MMP-2, -9 and TIMP-2

✍ M. Fujimura; M. Watanabe; H. Shimizu; T. Tominaga 📂 Article 📅 2006 🏛 Springer Vienna 🌐 English ⚖ 279 KB

Enhanced RNA expression of tissue inhibi

Enhanced RNA expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in human breast cancer

✍ Hitoshi Yoshiji; Daniel E. Gomez; Unnur P. Thorgeirsson 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 408 KB 👁 2 views

Tissue inhibitor of metalloproteinases-I (TIMP-I) is known to have at least 2 distinct types of activity, i.e., as a regulator of collagenolytic activity, and erythroid potentiating activity (EPA). In this study, we examined the expression of TIMP-I in human mammary carcinomas, non-malignant breast